Prospects of Using Domestic Hepatitis B Vaccines to Ensure Sanitary and Epidemiological Well-Being
https://doi.org/10.31631/2073-3046-2017-16-4-39-43
Abstract
On the basis of the literature review and own authors' researches, the results of assessment of safety and immunogenicity of native immunobiological medicinal preparations (hepatitis B vaccines «Combiotex», the combined vaccines Bubo-M and Bubo-Kok) in immunization of children and adults according to the National Immunizations Schedule and also medical workers for ensuring epidemic safety in the medical organizations are presented in this article. The prospects of native vaccines using in system of urgent actions for elimination of hepatitis B are defined.
About the Author
I. V. Fel'dblyum
Federal State Educational Institution of Higher Education «Perm State Medical University named after Academician E. A. Wagner» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
References
1. Mjakin’kova L.L., Bukach O.V., Logunova A.V. Modern problems, challenges and perspective directions in the field of vaccinology. Innovatika i jekspertiza. [Innovation and expertise]. 2015; 1 (14):96 – 109 (in Russian).
2. Prognosis of scientific and technological development of Russia: 2030. Biotechnology: 2030. Biotehnologii. Ed.: L.M. Gohberg, M.P. Kirpichnikov. Higher School of Economics .Moskow; 2014 (in Russian).
3. Prognosis of scientific and technological development of Russia: 2030. Medicine and Health Care. Ed.: L.M. Gohberg, L.M. Ogorodovoj. Higher School of Economics .Moskow; 2014 (in Russian).
4. New hepatitis data highlight need for urgent global response. Available at: http://www.who.int/mediacentre/news/releases/2017/global-hepatitis-report/ru/
5. WHO Global hepatitis report 2017. Available at: (http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?
6. Shakhgildyan I.V., Mikhailov M.I., Onishchenko G.G. Parenteral viral hepatitis (epidemiology, diagnosis, prevention). Moscow. 2005 (in Russian).
7. Balajan M.S., Mikhailov M.I. Encyclopaedic dictionary - viral hepatitis. Amipress. Moscow. 1994 (in Russian).
8. Hepatitis B, the virus, the disease, the vaccine. Ed.: Millman I.: Plenum Press. 1984:164
9. Mele A., Tancredi F., Romano L. et al. Effectiveness of Hepatitis V vaccination in babies born to Hepatitis V surface antigen-positive mothers in Italy. J. Infect. Dis. 200: 184 – 187.
10. Krymsky M.A., Krymsky R.M., Budanov M.V. Borisova V.N. Serotyping of vaccines against viral hepatitis B, present in the Russian pharmaceutical market. Materials of the scientific-practical conference «Vaccine prophylaxis: results, problems, perspectives». Perm’; 2010: 35 – 42 (in Russian).
11. Borisova V.N., Mel’nikov V.A. Domestic vaccine against hepatitis B. . Vakcinacija. [Vaccination].1999; 4: 10 (in Russian).
12. Sonnov V.N., Shamsheva O.V. Immunogenicity and reactogenicity of the domestic recombinant hepatitis B vaccine in premature infants..Voprosy gematologii/ onkologii i immunologii v pediatrii. [Questions of hematology / oncology and immunology in pediatrics]. 2010; 9 (3): 26 – 32 (in Russian).
13. Order No. 175n of the Ministry of Healthcare of the Russian Federation of April 13, 2017 «On Amendments to Appendices No. 1 and No. 2 to Order No. 125n of the Ministry of Health of the Russian Federation of March 21, 2014» On the Approval of the National immunization schedule and the Immunization Schedule Epidemic Indications. (in Russian).
14. Kaz’janin A.V., Fel’dblyum I.V., Konopleva O.V., Nikolaeva A.M., Perminova O.A., Borisova V.N. et al. On the possibility of using the combined vaccine Bubo-Kok in the national calendar of preventive vaccinations.. Jepidemiologija i vakcinoprofilaktika. [Epidemiology & Vaccinal prevention]. 2004; 5 (18): 11 – 13 (in Russian).
15. Fel’dbljum I.V., Vorob’eva N.N., Nikolaeva A.M., Borisova V.N., Mel’nikov V.A., Budanov M.V. Evaluation of the reactogenicity and immunogenicity of the domestic combined Bubo-M vaccine in immunition against diphtheria, tetanus and viral hepatitis B. Zhurnal mikrobiologii. [Journal of Microbiology]. 2001; 5: 27 – 30 (in Russian).
16. Organization and conduct of serological monitoring of the state of collective immunity to infections controlled by specific prevention (diphtheria, tetanus, whooping cough, measles, rubella, mumps, poliomyelitis, hepatitis B). Methodical instructions 3.1.2943-11, Moscow. 2011 (in Russian).
Review
For citations:
Fel'dblyum I.V. Prospects of Using Domestic Hepatitis B Vaccines to Ensure Sanitary and Epidemiological Well-Being. Epidemiology and Vaccinal Prevention. 2017;16(4):39-43. (In Russ.) https://doi.org/10.31631/2073-3046-2017-16-4-39-43
Views:
724
Email this article 